NCT06845839View on ClinicalTrials.gov

Study to Evaluate CAY001 in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy
Interventions
DRUG

CAY001

Polyphosphate (PolyP) - silica nanoparticle (SNP) complex

OTHER

Placebo

Vehicle - aqueous solution

Trial Locations (1)

07410

TKL Research, Fair Lawn

Sponsors
All Listed Sponsors
lead

Cayuga Biotech, Inc.

INDUSTRY